Outcomes of Liver Transplantation in Low Weight Children After Reducing the Lateral Segment of a Living Donor, Adapting the Shape and Size of the Graft to the Needs of the Recipient
Launched by HOSPITAL ITALIANO DE BUENOS AIRES · Jul 19, 2018
Trial Information
Current as of June 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \< or = 17 years old.
- • Having undergone live donor liver transplantation.
- • Having received hyper-reduced liver grafts
- • At the Liver Transplantation Unit of the Hospital Italiano de Buenos Aires
- • Between June 1997 and April 2018
- Exclusion Criteria:
- • \> 17 years old.
- • Cadaveric liver transplant
- • Whole liver grafts.
About Hospital Italiano De Buenos Aires
Hospital Italiano de Buenos Aires is a leading healthcare institution dedicated to advancing medical research and patient care. Renowned for its commitment to clinical excellence and innovation, the hospital actively participates in a range of clinical trials aimed at developing new treatment modalities and improving healthcare outcomes. With a multidisciplinary team of experienced healthcare professionals, Hospital Italiano combines cutting-edge technology with a patient-centered approach, ensuring the highest standards of safety and efficacy in all research endeavors. As a trusted sponsor, the hospital is committed to contributing to the global medical community through rigorous scientific investigations and collaboration with various stakeholders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Capital Federal, , Argentina
Patients applied
Trial Officials
Micaela Raices, Physician
Principal Investigator
Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Matias E Czerwonko, Physician
Study Chair
Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Victoria Ardiles, Physician
Study Chair
Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Gustavo Boldrini, Physician
Study Chair
Department of Pediatrics, Division of Pediatric Gastroenterology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Daniel D'Agostino, Physician
Study Chair
Department of Pediatrics, Division of Pediatric Gastroenterology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
José Marcó del Pont, Physician
Study Chair
Department of Pediatrics, Division of Pediatric Infectious Diseases, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Juan Pekolj, Doctor
Study Chair
Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Eduardo de Santibañes, Doctor
Study Chair
Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Martin de Santibañes, Physician
Study Director
Department of General Surgery, Division of HPB Surgery and Liver Transplant Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials